deoxyepinephrine has been researched along with Intraocular Pressure in 26 studies
Deoxyepinephrine: Sympathomimetic, vasoconstrictor agent.
Intraocular Pressure: The pressure of the fluids in the eye.
| Excerpt | Relevance | Reference |
|---|---|---|
| "An ibopamine challenge is a novel technique for assessing glaucoma using ibopamine, a topical drug which temporarily increases aqueous production." | 9.20 | Ibopamine challenge testing differentiates glaucoma suspect, stable glaucoma and progressive glaucoma cases. ( Craig, JE; Landers, J; Ullrich, K, 2015) |
| "To study whether topical ibopamine effectively increases the intraocular pressure in patients with ocular hypotony after vitreoretinal surgery, uveitis, or penetrating trauma." | 9.12 | Topical ibopamine in the treatment of chronic ocular hypotony attributable to vitreoretinal surgery, uveitis, or penetrating trauma. ( Cohen, AC; Ganteris, E; Jansen, J; Mulder, PG; Ugahary, LC; van Meurs, JC; Veckeneer, M, 2006) |
| "On the basis of intraocular pressure measurements and fluorophotometry we assessed the effects of 2% ibopamine eye drops on aqueous humor production in normal and glaucomatous eyes." | 9.10 | Effects of ibopamine eye drops on intraocular pressure and aqueous humor flow in healthy volunteers and patients with open-angle glaucoma. ( Azevedo, H; Ciarniello, MG; Cunha-Vaz, J; Dionisio, P; Rosignoli, MT, 2003) |
| "The aim of the study was to determine the effects of a dopaminergic drug, 2% ibopamine, on the pupil, intraocular pressure and other ocular and ultrasound biometric variables." | 9.09 | Effects of 2% ibopamine on pupil, refraction, anterior segment anatomy and intraocular pressure. ( Babighian, S; Bonomi, L; Marchini, G; Perfetti, S; Tosi, R, 2001) |
| "Ibopamine 2% eye drops have a positive pressure effect in 50% of suspected normal-tension glaucoma eyes and may differentiate between eyes with normal trabecular outflow capacity and eyes with increased resistance in the trabecular meshwork that are prone to pressure peaks and deterioration to glaucoma." | 7.74 | [Positive ibopamine provocative test in normal-tension glaucoma suspects]. ( Gloor, BP; Kniestedt, C; Romppainen, T; Stürmer, J, 2007) |
| "The purpose of this study was to measure the effect of topical ibopamine and epinephrine on intraocular pressure in undisturbed rabbits." | 7.70 | Comparison of effects of topical ibopamine and epinephrine on the circadian rhythm of intraocular pressure of the rabbit eye as measured by telemetry. ( Bachman, LA; Brubaker, RF; McLaren, JW, 1999) |
| "A glaucoma patient with a positive ibopamine challenge will show a negative challenge result when re-tested following trabeculectomy surgery." | 5.22 | Ibopamine challenge testing becomes negative following successful trabeculectomy surgery. ( Craig, JE; Landers, J; Ullrich, K, 2016) |
| "An ibopamine challenge is a novel technique for assessing glaucoma using ibopamine, a topical drug which temporarily increases aqueous production." | 5.20 | Ibopamine challenge testing differentiates glaucoma suspect, stable glaucoma and progressive glaucoma cases. ( Craig, JE; Landers, J; Ullrich, K, 2015) |
| "To study whether topical ibopamine effectively increases the intraocular pressure in patients with ocular hypotony after vitreoretinal surgery, uveitis, or penetrating trauma." | 5.12 | Topical ibopamine in the treatment of chronic ocular hypotony attributable to vitreoretinal surgery, uveitis, or penetrating trauma. ( Cohen, AC; Ganteris, E; Jansen, J; Mulder, PG; Ugahary, LC; van Meurs, JC; Veckeneer, M, 2006) |
| "The results confirm the potent mydriatic effect of 2% ibopamine, which is greater than that of either 10% phenylephrine or 1% tropicamide, as well as its ability to induce an increase in intraocular pressure when used in patients with glaucoma alone." | 5.10 | Comparative study of the effects of 2% ibopamine, 10% phenylephrine, and 1% tropicamide on the anterior segment. ( Babighian, S; Bonomi, L; Marchini, G; Perfetti, S; Tosi, R, 2003) |
| "On the basis of intraocular pressure measurements and fluorophotometry we assessed the effects of 2% ibopamine eye drops on aqueous humor production in normal and glaucomatous eyes." | 5.10 | Effects of ibopamine eye drops on intraocular pressure and aqueous humor flow in healthy volunteers and patients with open-angle glaucoma. ( Azevedo, H; Ciarniello, MG; Cunha-Vaz, J; Dionisio, P; Rosignoli, MT, 2003) |
| "The effects of topical ibopamine on pupillary diameter, aqueous humor flow measured by fluorophotometry, and intraocular pressure were studied in 24 healthy, blue-eyed humans." | 5.10 | Effect of ibopamine on aqueous humor production in normotensive humans. ( Brubaker, RF; Ciarniello, MG; Dionisio, P; Herman, DC; McLaren, JW; Nau, CB; Rosignoli, MT; Wayman, LL, 2003) |
| "The aim of the study was to determine the effects of a dopaminergic drug, 2% ibopamine, on the pupil, intraocular pressure and other ocular and ultrasound biometric variables." | 5.09 | Effects of 2% ibopamine on pupil, refraction, anterior segment anatomy and intraocular pressure. ( Babighian, S; Bonomi, L; Marchini, G; Perfetti, S; Tosi, R, 2001) |
| "The purpose of the study was to assess the effect of ibopamine (3,4 di-isobutyrrylester of N-methyldopamine), a D1-dopamine agonist, on intraocular pressure (IOP) in offspring of parents with primary openangle glaucoma as a consequence of outflow structures impairment." | 3.79 | Ibopamine: D1-dopaminergic agonist in the diagnosis of glaucoma. ( Brusini, P; De Gregorio, F; Di Staso, S; Pecori Giraldi, J; Sampaolesi, R; Stecchi, G; Taloni, M; Virno, M, 2013) |
| "Ibopamine 2% eye drops have a positive pressure effect in 50% of suspected normal-tension glaucoma eyes and may differentiate between eyes with normal trabecular outflow capacity and eyes with increased resistance in the trabecular meshwork that are prone to pressure peaks and deterioration to glaucoma." | 3.74 | [Positive ibopamine provocative test in normal-tension glaucoma suspects]. ( Gloor, BP; Kniestedt, C; Romppainen, T; Stürmer, J, 2007) |
| "The purpose of this study was to measure the effect of topical ibopamine and epinephrine on intraocular pressure in undisturbed rabbits." | 3.70 | Comparison of effects of topical ibopamine and epinephrine on the circadian rhythm of intraocular pressure of the rabbit eye as measured by telemetry. ( Bachman, LA; Brubaker, RF; McLaren, JW, 1999) |
| "We report here the results obtained in a group of 52 eyes affected by open-angle Glaucoma (OAG), whose intraocular pressure (IOP) was inadequately controlled by two drugs of different pharmacological categories, into which there was introduced Latanoprost, both in place of one of the two drugs and in addition to the preceding therapy." | 3.70 | Latanoprost and the ibopamine test: a year's experience. ( Mollicone, A; Pecori Giraldi, J; Seguto, D; Simeone, L; Zaccara, F, 2000) |
| "The ibopamine test was performed in all patients who were then followed up with diagnostic tests for glaucoma, visual fields, and spectral-domain optical coherence tomography." | 1.43 | Early Glaucoma Screening Using the Ibopamine Provocative Test. ( Barojas-Weber, E; Barrientos-Gutiérrez, T; Domínguez-Dueñas, F; Jiménez-Reynoso, CA; Mundo-Fernández, EE; Plaza-Espinosa, L, 2016) |
| "The ibopamine test was positive at time "0" (study begins) in 48." | 1.31 | Ocular hypertension: 12 years' follow-up. ( Cordiani, B; De Benedetti, G; Paone, E; Pecori Giraldi, J; Repossi, A, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (3.85) | 18.7374 |
| 1990's | 4 (15.38) | 18.2507 |
| 2000's | 16 (61.54) | 29.6817 |
| 2010's | 5 (19.23) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Landers, J | 2 |
| Ullrich, K | 2 |
| Craig, JE | 2 |
| Domínguez-Dueñas, F | 1 |
| Plaza-Espinosa, L | 1 |
| Mundo-Fernández, EE | 1 |
| Jiménez-Reynoso, CA | 1 |
| Barojas-Weber, E | 1 |
| Barrientos-Gutiérrez, T | 1 |
| Salvetat, ML | 1 |
| Zeppieri, M | 1 |
| Tosoni, C | 1 |
| Brusini, P | 2 |
| Virno, M | 3 |
| Sampaolesi, R | 1 |
| Pecori Giraldi, J | 4 |
| De Gregorio, F | 3 |
| Taloni, M | 1 |
| Di Staso, S | 3 |
| Stecchi, G | 1 |
| Marchini, G | 2 |
| Babighian, S | 2 |
| Tosi, R | 2 |
| Perfetti, S | 2 |
| Bonomi, L | 2 |
| Azevedo, H | 1 |
| Ciarniello, MG | 2 |
| Rosignoli, MT | 2 |
| Dionisio, P | 2 |
| Cunha-Vaz, J | 1 |
| McLaren, JW | 2 |
| Herman, DC | 1 |
| Brubaker, RF | 2 |
| Nau, CB | 1 |
| Wayman, LL | 1 |
| Magacho, L | 1 |
| Lima, FE | 1 |
| Costa, ML | 1 |
| Fayad, FA | 1 |
| Guimarães, NL | 1 |
| Avila, MP | 1 |
| Ugahary, LC | 1 |
| Ganteris, E | 1 |
| Veckeneer, M | 1 |
| Cohen, AC | 1 |
| Jansen, J | 1 |
| Mulder, PG | 1 |
| van Meurs, JC | 1 |
| Kniestedt, C | 1 |
| Romppainen, T | 1 |
| Gloor, BP | 1 |
| Stürmer, J | 1 |
| Potter, DE | 1 |
| Burke, JA | 1 |
| Chang, FW | 1 |
| De Benedetti, G | 2 |
| Santarelli, S | 1 |
| Liguori, A | 1 |
| Mollicone, A | 2 |
| D'Ubaldo, E | 2 |
| Sallucci, S | 1 |
| De Stefano, C | 2 |
| Sedran, L | 1 |
| Lo Presti, L | 1 |
| Morgese, A | 1 |
| Ravot, M | 1 |
| Brogliatti, B | 2 |
| Boles Carenini, B | 2 |
| Bachman, LA | 1 |
| Giuffré, I | 1 |
| Taverniti, L | 2 |
| Balestrazzi, E | 1 |
| Pannarale, MR | 1 |
| Boles Carenini, A | 1 |
| Bogetto, C | 1 |
| Vadalà, G | 1 |
| Grignolo, FM | 1 |
| Repossi, A | 1 |
| Cordiani, B | 1 |
| Paone, E | 1 |
| Di Giulio, S | 1 |
| Boccassini, B | 1 |
| Boccassini, G | 1 |
| Arrico, L | 1 |
| Grenga, R | 1 |
| Seguto, D | 1 |
| Simeone, L | 1 |
| Zaccara, F | 1 |
| Soltau, JB | 1 |
| Accorinti, M | 1 |
| Ciapparoni, V | 1 |
| Pirraglia, MP | 1 |
| Pivetti-Pezzi, P | 1 |
7 trials available for deoxyepinephrine and Intraocular Pressure
| Article | Year |
|---|---|
Ibopamine challenge testing differentiates glaucoma suspect, stable glaucoma and progressive glaucoma cases.
Topics: Aged; Aged, 80 and over; Deoxyepinephrine; Disease Progression; Dopamine Agonists; Female; Glaucoma; | 2015 |
Ibopamine challenge testing becomes negative following successful trabeculectomy surgery.
Topics: Aged; Aged, 80 and over; Antihypertensive Agents; Deoxyepinephrine; Disease Progression; Dopamine Ag | 2016 |
Comparative study of the effects of 2% ibopamine, 10% phenylephrine, and 1% tropicamide on the anterior segment.
Topics: Adult; Aged; Anterior Eye Segment; Deoxyepinephrine; Dose-Response Relationship, Drug; Female; Glauc | 2003 |
Effects of ibopamine eye drops on intraocular pressure and aqueous humor flow in healthy volunteers and patients with open-angle glaucoma.
Topics: Adult; Aqueous Humor; Deoxyepinephrine; Female; Fluorophotometry; Glaucoma, Open-Angle; Humans; Intr | 2003 |
Effect of ibopamine on aqueous humor production in normotensive humans.
Topics: Adrenergic alpha-Antagonists; Adult; Aqueous Humor; Cross-Over Studies; Deoxyepinephrine; Double-Bli | 2003 |
Topical ibopamine in the treatment of chronic ocular hypotony attributable to vitreoretinal surgery, uveitis, or penetrating trauma.
Topics: Administration, Topical; Adult; Aged; Chronic Disease; Cross-Over Studies; Deoxyepinephrine; Dopamin | 2006 |
Effects of 2% ibopamine on pupil, refraction, anterior segment anatomy and intraocular pressure.
Topics: Adrenergic alpha-Antagonists; Adult; Aged; Anterior Eye Segment; Deoxyepinephrine; Dopamine Agonists | 2001 |
19 other studies available for deoxyepinephrine and Intraocular Pressure
| Article | Year |
|---|---|
Early Glaucoma Screening Using the Ibopamine Provocative Test.
Topics: Aged; Deoxyepinephrine; Diagnostic Techniques, Ophthalmological; Dopamine Agonists; Female; Glaucoma | 2016 |
Baseline factors predicting the risk of conversion from ocular hypertension to primary open-angle glaucoma during a 10-year follow-up.
Topics: Aged; Deoxyepinephrine; Disease Progression; Female; Follow-Up Studies; Glaucoma, Open-Angle; Humans | 2016 |
Ibopamine: D1-dopaminergic agonist in the diagnosis of glaucoma.
Topics: Adolescent; Adult; Child; Deoxyepinephrine; Dopamine Agonists; Female; Glaucoma, Open-Angle; Humans; | 2013 |
Ibopamine provocative test and glaucoma: consideration of factors that may influence the examination.
Topics: Adult; Antihypertensive Agents; Deoxyepinephrine; Dopamine Agonists; False Positive Reactions; Femal | 2004 |
[Positive ibopamine provocative test in normal-tension glaucoma suspects].
Topics: Deoxyepinephrine; Female; Glaucoma; Humans; Intraocular Pressure; Male; Middle Aged; Mydriatics; Rep | 2007 |
Alteration in ocular function induced by phenylethylamine analogs of dopamine.
Topics: Animals; Blinking; Blood Pressure; Deoxyepinephrine; Dopamine; Dose-Response Relationship, Drug; Int | 1984 |
Normal tension glaucoma: a ten-year follow-up.
Topics: Adult; Anterior Eye Segment; Deoxyepinephrine; Dopamine Agonists; Female; Follow-Up Studies; Glaucom | 1997 |
Effects of adrenergics, adrenolytics, cholinergics and carbonic anhydrase inhibitors on ibopamine-induced ocular hypertension in POAG.
Topics: Adrenergic Agonists; Adrenergic Antagonists; Aqueous Humor; Carbonic Anhydrase Inhibitors; Cholinerg | 1997 |
Ultrabiomicroscopic study of the effects of brimonidine, apraclonidine, latanoprost and ibopamine on the chamber angle and ciliary body.
Topics: Adrenergic alpha-Agonists; Aged; Anterior Chamber; Brimonidine Tartrate; Ciliary Body; Clonidine; De | 1998 |
Comparison of effects of topical ibopamine and epinephrine on the circadian rhythm of intraocular pressure of the rabbit eye as measured by telemetry.
Topics: Animals; Circadian Rhythm; Deoxyepinephrine; Epinephrine; Intraocular Pressure; Mydriatics; Rabbits; | 1999 |
Evaluation of near-refraction after administration of ibopamine 2%.
Topics: Aged; Aged, 80 and over; Deoxyepinephrine; Female; Humans; Intraocular Pressure; Male; Middle Aged; | 2000 |
Ocular pressure increase by ibopamine discloses aqueous humour outflow changes in normal tension eyes.
Topics: Aqueous Humor; Deoxyepinephrine; Glaucoma, Open-Angle; Homeostasis; Humans; Intraocular Pressure; Mi | 2000 |
Ibopamine test in healthy and glaucomatous eyes: tonometric and pupillographic study.
Topics: Aged; Aqueous Humor; Deoxyepinephrine; Dopamine Agonists; Female; Glaucoma, Open-Angle; Humans; Intr | 2000 |
Ocular hypertension: 12 years' follow-up.
Topics: Deoxyepinephrine; Female; Follow-Up Studies; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Mal | 2000 |
Post-trabeculectomy hypotension and hypoathalamia: efficacy of treatment with ibopamine eyedrops.
Topics: Deoxyepinephrine; Dopamine Agonists; Glaucoma, Open-Angle; Humans; Hypotension; Intraocular Pressure | 2000 |
The ibopamine test in patients affected by monolateral pseudoexfoliative glaucoma.
Topics: Aqueous Humor; Deoxyepinephrine; Dopamine Agonists; Exfoliation Syndrome; Glaucoma; Humans; Intraocu | 2000 |
Latanoprost and the ibopamine test: a year's experience.
Topics: Aged; Antihypertensive Agents; Aqueous Humor; Deoxyepinephrine; Dopamine Agonists; Female; Glaucoma, | 2000 |
Treatment of severe ocular hypotony in AIDS patients with cytomegalovirus retinitis and cidofovir-associated uveitis.
Topics: AIDS-Related Opportunistic Infections; Animals; Antiviral Agents; Cidofovir; Cytomegalovirus Retinit | 2001 |
Treatment of severe ocular hypotony in AIDS patients with cytomegalovirus retinitis and cidofovir-associated uveitis.
Topics: Adult; AIDS-Related Opportunistic Infections; Antiretroviral Therapy, Highly Active; Antiviral Agent | 2001 |